Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Meds Apotek AB (publ)'s Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was kr5 Mil. Therefore, Meds Apotek AB (publ)'s EV-to-EBIT ratio for today is 63.30.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Meds Apotek AB (publ)'s Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was kr24 Mil. Therefore, Meds Apotek AB (publ)'s EV-to-EBITDA ratio for today is 13.81.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Meds Apotek AB (publ) (OSTO:MEDS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Meds Apotek AB (publ)'s EV-to-EBITDA for today is:
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr24 Mil.
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,080 Mil.
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr14 Mil.
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil.
Meds Apotek AB (publ)'s Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) Enterprise Value Related Terms
Meds Apotek AB (publ) Enterprise Value Historical Data
* Premium members only.
The historical data trend for Meds Apotek AB (publ)'s Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MEDS vs AMZN, BABA, PDD: Enterprise Value Comparison
For the Internet Retail subindustry, Meds Apotek AB (publ)'s Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) Enterprise Value vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s Enterprise Value distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s Enterprise Value falls into.
Meds Apotek AB (publ) Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Meds Apotek AB (publ)'s Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) (OSTO:MEDS) has a Enterprise Value of kr329 Mil as of Jul. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Meds Apotek AB (publ) and its competitors.
Is Meds Apotek AB (publ)'s Enterprise Value too high?
Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Enterprise Value compare to AMZN and BABA?
Meds Apotek AB (publ)'s Enterprise Value of kr329 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Retail - Cyclical company?
A good Enterprise Value depends on the Retail - Cyclical industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Meds Apotek AB (publ) and its competitors. Meds Apotek AB (publ)'s current Enterprise Value is kr329 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (OSTO:MEDS) has a current Enterprise Value of kr329 Mil. The current Enterprise Value is kr329 Mil. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Meds Apotek AB (publ) (OSTO:MEDS), the current Enterprise Value is kr329 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score
Get the complete analysis for OSTO:MEDS
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MEDS has been successfully added to your 
